文献速递慢性肾脏病肾移植

基于eGFR的等待名单资格后CKD进展与移植可及性的种族差异

CKD Progression From the Time of Estimated GFR-Based Waitlist Eligibility and Racial Disparities in Transplant Access.
PubMed 文献 · Am J Kidney Dis · 2021-09-17

该回顾性队列研究比较了Black、Hispanic和White患者在eGFR≤20 mL/min/1.73 m²后进展至肾衰竭替代治疗(KFRT)的时间,并评估eGFR公式中种族项对等待名单资格的影响。发现Black和Hispanic患者KFRT风险更高,且将Black患者编码为非Black可提前约0.5年激活等待名单,但无法消除差异。

要点

  • Black和Hispanic患者达到eGFR≤20后3年内KFRT累积发生率高于White患者。
  • 将Black患者按非Black编码估算eGFR可提前中位0.5年激活等待名单。
  • 统一eGFR阈值减少了Black和Hispanic患者进入移植等待名单的机会。

核心结论

  • 统一eGFR阈值使Black和Hispanic患者进入移植等待名单的机会减少。
  • 将Black患者按非Black编码估算eGFR可显著提前等待名单激活,但不能消除其与White患者相比更短的KFRT时间和更少的抢先移植机会。

研究设计与样本

  • 回顾性队列研究,使用OptumLabs Data Warehouse数据。
  • 纳入40,042名White、8,519名Black和3,569名Hispanic患者,均有至少一次eGFR在20-60 mL/min/1.73 m²之间且2008-2018年间门诊eGFR≤20 mL/min/1.73 m²。
  • 另基于将Black患者编码为非Black重新组装Black患者队列(n=11,269)。

主要发现

  • 3年时KFRT累积发生率:White患者20.5%,Hispanic患者40.9%,Black患者(种族项编码为Black)36%,Black患者(种族项编码为非Black)28.7%。
  • 完全调整分析中,Black患者(HR 1.28 [95% CI 1.15-1.43])和Hispanic患者(HR 1.66 [95% CI 1.18-2.31])的KFRT风险高于White患者。
  • 基于eGFR下降斜率,将Black患者编码为非Black可提前中位0.5年(IQR 0.27-1.23)激活等待名单。

临床怎么用

  • 临床中应意识到eGFR公式中种族项可能影响Black患者移植等待名单的及时性。
  • 对于Black患者,考虑使用不含种族项的eGFR估算可能提前等待名单激活,但需综合评估。

局限性

  • 无法排除若经全面评估后不适合作为肾移植候选者的个体。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

RATIONALE & OBJECTIVE: Equations for estimated glomerular filtration rate (eGFR) that incorporate a term for race assign a higher value to Black individuals compared to non-Black individuals for the same sex, age, and serum creatinine concentration. This difference may contribute to racial disparities in kidney transplant access. We sought to (1) compare time from meeting a transplant eligibility threshold of eGFR ≤20 mL/min/1.73 m2 to kidney failure with replacement therapy (KFRT) among Black, Hispanic, and White patients, and (2) assess the impact of incorporation of race into eGFR expressions on establishment of waitlist eligibility and time from eligibility to KFRT. STUDY DESIGN: Retrospective cohort. SETTING & PARTICIPANTS: Using the OptumLabs Data Warehouse, we assembled a cohort of 40,042 White, 8,519 Black, and 3,569 Hispanic patients having at least one eGFR value between 20 and 60 mL/min/1.73 m2 within the preceding 2 years and an incident outpatient eGFR of ≤20 mL/min/1.73 m2 between 2008-2018, using the CKD-EPI creatinine equation that includes a term for race coded as Black or non-Black. We then reassembled a Black patient cohort based on incident eGFR ≤20 mL/min/1.73 m2 (n = 11,269) estimated using the same CKD-EPI equation but coding Black patients as non-Black. EXPOSURE: Race/ethnicity. OUTCOME: Time to KFRT. ANALYTICAL APPROACH: Unadjusted and adjusted Fine-Gray models; linear regression to compute eGFR slopes. RESULTS: By 3 years, the cumulative incidence of KFRT was 20.5% among White patients, 40.9% among Hispanic patients, 36% among Black patients whose GFR was estimated using a race term coded as Black, and 28.7% among Black patients whose GFR was estimated using a race term coded as non-Black. In fully adjusted analyses including 11,269 Black patients with an eGFR ≤20 mL/min/1.73 m2 based on coding them as non-Black, KFRT risk remained greater among Black (HR, 1.28 [95% CI, 1.15-1.43]) and Hispanic (HR, 1.66 [95% CI, 1.18-2.31]) patients than among White patients. Based on slopes of eGFR decline, coding Black patients as non-Black would allow earlier waitlist activation by an estimated median of 0.5 [interquartile range, 0.27-1.23] years. LIMITATIONS: Inability to exclude individuals who would not be kidney transplant candidates if comprehensively evaluated. CONCLUSIONS: A uniform eGFR threshold provides less opportunity for being placed on the transplant waitlist among Black and Hispanic patients. For many Black patients, estimation of GFR as if their race category were non-Black would allow substantially earlier waitlisting but would not eliminate their shorter time to KFRT and reduced opportunity for preemptive transplantation compared with White patients.

来源:Am J Kidney Dis,查看原文。版权归原作者所有。

引用

  1. Chu CD, Powe NR, Crews DC, et al. CKD Progression From the Time of Estimated GFR-Based Waitlist Eligibility and Racial Disparities in Transplant Access. Am J Kidney Dis. 2021. PMID: 34543686. doi:10.1053/j.ajkd.2021.08.010

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。